Louis Brenner, Hopewell Therapeutics CEO
June 7, 2023 11:23 AM EDTUpdated 04:05 PM
Financing

LNP biotech looks to go be­yond the liv­er, rais­ing $25M in seed mon­ey to move for­ward

Paul Schloesser

Associate Editor

Hopewell Ther­a­peu­tics an­nounced $25 mil­lion in seed fund­ing on Wednes­day, with the Boston-area biotech look­ing to make the next break­through in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times